Great Basin Scientific Inc (NASDAQ:GBSN) a popular molecular diagnostics firm reported a cost reduction and restructuring plan that is designed to put resources on areas that will help to support the revenue growth of its prevailing commercial product line. As a considerable part of the restructuring program, the company has streamlined certain administrative and manufacturing processes and will reduce almost 50 employees countrywide.

The details

Between these changes, together with other previously executed cost declines and added efficiencies, Great Basin anticipates to eliminate between $10 million and $12 million from its cash burn of the year. The firm reported that it has notably reduced the Convertible Note for the last year to $36 million. Ryan Ashton, the CEO of Great Basin, reported that since the firm’s inception, they have focused on establishing a pipeline of molecular diagnostics offerings that offer a unique and powerful combinations of low cost, ease-of-use and menu versatility.

This investment in operations infrastructure and R&D has resulted in prevailing product menu of 4 FDA-cleared tests and also panels with 2 additional assays in the FDA’s 510(k) process. Customer anticipation to expanding menu has been promising, and they are undertaking these changes to confirm that they are well-positioned to advance the firm sustainably and aggressively.

Great Basin does not project material pre-tax charges as an outcome of the cost reduction and restructuring plan. Numerous cost reduction measures will be commenced immediately, with all measures anticipated to be substantially closed by the close of the current quarter. The firm is continuing advancement of its previously reported assays and expects to begin new clinical studies later in 2017.

Great Basin has finalized a deal with 2016 Convertible Note holders to lessen the Note’s principal amount by $35.6 million to $36.3 million due as of February 9, 2017. In lieu, the cash amount in the firm’s restricted cash account will be lowered to $21.5 million from $57 million.

Previous articleMentor Capital Inc (OTCMKTS:MNTR) Eyes OTCQX
Next articleFederal Home Loan Mortgage Corp (OTCMKTS:FMCC) Prices Reopening of 1.50% 3-Year Reference Notes Security
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg,,, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.